. 2021 Jul 28;10(9):1035–1044. doi: 10.1530/EC-21-0257
This work is licensed under a Table 2.
Clinical characteristics of the control and polycystic ovary syndrome groups.
| CON | PCOS | P-value | |
|---|---|---|---|
| n (%) | n (%) | ||
| Acne | 12 (22.6) | 95 (56.9) | <0.001 |
| Hirsutism | 12 (22.2) | 91 (54.5) | <0.001 |
| PCOM | 1 (2.5) | 126 (81.8) | <0.001 |
| Overweight | 47 (24.6) | 76 (40.6) | <0.001 |
| Obesity | 17 (8.9) | 38 (20.3) | 0.002 |
| Central obesity | 38 (24.5) | 66 (37.3) | 0.01 |
| MS | 3 (6.4) | 26 (16) | 0.09 |
| IR | 17 (32.1) | 61 (37) | 0.52 |
CON, control subjects; IR, insulin resistance; MS, metabolic syndrome; PCOM, polycystic ovarian morphology at ultrasound; PCOS, polycystic ovary syndrome patients; insulin resistance, homeostasis model assessment for insulin resistance index > 2.5.